Harvard Bioscience Inc. (HBIO) PT Raised to $7 at Benchmark, 'Q1 Beat & Raise; Outlook Improving; Raising Price Target'

Go back to Harvard Bioscience Inc. (HBIO) PT Raised to $7 at Benchmark, 'Q1 Beat & Raise; Outlook Improving; Raising Price Target'

Form 8-K HARVARD BIOSCIENCE INC For: Apr 25

April 25, 2023 8:01 AM EDT

0001123494 false 0001123494 2023-04-25 2023-04-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares... More